Teladoc price target lowered to $34 from $37 at Canaccord

Canaccord lowered the firm’s price target on Teladoc to $34 from $37 and keeps a Buy rating on the shares. The firm said they posted another quarter of strong adjusted EBITDA and free cash flow results as the company increasingly focuses on balancing revenue growth and bottom-line performance.